• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Neurosurg Open . Outcomes and Spectrum of Major Neurovascular Events Among COVID-19 Patients: A 3-Center Experience

tetano

Editor, Senior Moderator
Neurosurg Open


. 2020 Sep;1(3):okaa008.
doi: 10.1093/neuopn/okaa008. Epub 2020 Jul 17.
Outcomes and Spectrum of Major Neurovascular Events Among COVID-19 Patients: A 3-Center Experience


Blake E S Taylor[SUP] 1 [/SUP], Priyank Khandelwal[SUP] 1 [/SUP], Michael S Rallo[SUP] 2 [/SUP], Purvee Patel[SUP] 1 [/SUP], Lindsey Smith[SUP] 3 [/SUP], Hai Sun[SUP] 4 [/SUP], Anil Nanda[SUP] 1 [/SUP], Amit Singla[SUP] 1 [/SUP], Sudipta Roychowdhury[SUP] 4 [/SUP], Roger C Cheng[SUP] 5 [/SUP], Kiwon Lee[SUP] 5 [/SUP], Gaurav Gupta[SUP] 1 [/SUP], Stephen A Johnson[SUP] 4 [/SUP]



Affiliations

Abstract

Background: Preliminary data suggest that Coronavirus Disease-2019 (COVID-19) is associated with hypercoagulability and neurovascular events, but data on outcomes is limited.
Objective: To report the clinical course and outcomes of a case series of COVID-19 patients with a variety of cerebrovascular events.
Methods: We performed a multicentric, retrospective chart review at our three academic tertiary care hospitals, and identified all COVID-19 patients with cerebrovascular events requiring neuro-intensive care and/or neurosurgical consultation.
Results: We identified 26 patients between March 1 and May 24, 2020, of whom 12 (46%) died. The most common event was a large-vessel occlusion (LVO) in 15 patients (58%), among whom 8 died (8/15, 53%). A total of 9 LVO patients underwent mechanical thrombectomy, of whom 5 died (5/9, 56%). A total of 7 patients (27%) presented with intracranial hemorrhage. Of the remaining patients, 2 had small-vessel occlusions, 1 had cerebral venous sinus thrombosis, and another had a vertebral artery dissection. Acute Respiratory Distress Syndrome occurred in 8 patients, of whom 7 died. Mortalities had a higher D-dimer on admission (mean 20 963 ng/mL) than survivors (mean 3172 ng/mL). Admission Glasgow Coma Scale (GCS) score was poor among mortalities (median 7), whereas survivors had a favorable GCS at presentation (median 14) and at discharge (median 14).
Conclusion: COVID-19 may be associated with hemorrhage as well as ischemia, and prognosis appears poorer than expected-particularly among LVO cases, where outcome remained poor despite mechanical thrombectomy. However, a favorable neurological condition on admission and lower D-dimer may indicate a better outcome.

Keywords: COVID-19; Cerebral venous sinus thrombosis; Intracranial hemorrhage; Large-vessel occlusion (LVO).
 
Back
Top Bottom